Overview Fundamentals API Earnings EOD API Sample Code Pricing

Eterna Therapeutics Inc (ERNA NASDAQ) stock market data APIs

$2 -0.09(-4.3%) as of July 15, 2024
Price chart is built with Anychart

Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Eterna Therapeutics Inc Financial Data Overview

11 091 K
5 410 K
115 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ERNA',
Type: 'Common Stock',
Name: 'Eterna Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000CX5677',
CIK: '748592',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '1992-10-19',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Eterna Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 115 K
  • EBITDA -21 044 000
  • Earnings Per Share -4.25
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Eterna Therapeutics Inc Earnings via APIs

  • Latest Release 2023-11-13
  • EPS/Forecast NaN

Get Eterna Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?